Article Text

PDF
Mitomycin C, with or without surgery, for the treatment of ocular squamous cell carcinoma in horses
  1. F. Malalana, DVM, MRCVS1,
  2. D. Knottenbelt, BVM&S, DVMS, DipECEIM, MRCVS1 and
  3. S. McKane, BVSc, BSc(vet), PhD, DipACVIM, DipECEIM, MRCVS1
  1. 1 Philip Leverhulme Equine Hospital, University of Liverpool, Leahurst, Chester High Road, Neston, Cheshire CH64 7TE
  1. E-mail for correspondence: fernmala{at}liverpool.ac.uk

Abstract

Ocular lesions in horses, confirmed as squamous cell carcinoma, were treated topically with mitomycin C. Fourteen horses with confirmed ocular squamous cell carcinoma, three of which were affected bilaterally, were included in the study. Eight of the affected eyes were treated topically with mitomycin C alone; in the other nine eyes, the tumours were surgically removed and topical treatment with mitomycin C was then applied. The treatment protocol consisted of 0.2 ml of 0.04 per cent mitomycin C instilled into the conjunctival sac of the affected eye, every six hours, in rounds of seven days of treatment followed by seven days without treatment. This was repeated until full regression of the tumour occurred (up to four rounds of treatment with mitomycin C). Of the eight eyes treated with mitomycin C alone (without surgery), clinical resolution occurred in six cases. Of the nine eyes treated with a combination of surgery and topical mitomycin C, clinical resolution occurred in seven cases. No complications were observed.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.